In our study, 18.67% of CRC cases exhibited PIK3CA mutations, a rate that aligns with global trends (10–20%) and closely correspondence those found in Australia, France, Italy, and Japan (14%–17.8%) (39). Here, PIK3CA is linked to colorectal carcinoma.